- Research article
- Open Access
CC3/TIP30 affects DNA damage repair
© Fong et al; licensee BioMed Central Ltd. 2010
- Received: 22 October 2009
- Accepted: 7 April 2010
- Published: 7 April 2010
The pro-apoptotic protein CC3/TIP30 has an unusual cellular function as an inhibitor of nucleocytoplasmic transport. This function is likely to be activated under conditions of stress. A number of studies support the notion that CC3 acts as a tumor and metastasis suppressor in various types of cancer. The yeast homolog of CC3 is likely to be involved in responses to DNA damage. Here we examined the potential role of CC3 in regulation of cellular responses to genotoxic stress.
We found that forced expression of CC3 in CC3-negative cells strongly delays the repair of UV-induced DNA damage. Exogenously introduced CC3 negatively affects expression levels of DDB2/XPE and p21CIP1, and inhibits induction of c-FOS after UV exposure. In addition, exogenous CC3 prevents the nuclear accumulation of P21CIP in response to UV. These changes in the levels/localization of relevant proteins resulting from the enforced expression of CC3 are likely to contribute to the observed delay in DNA damage repair. Silencing of CC3 in CC3-positive cells has a modest delaying effect on repair of the UV induced damage, but has a much more significant negative affect on the translesion DNA synthesis after UV exposure. This could be related to the higher expression levels and increased nuclear localization of p21CIP1 in cells where expression of CC3 is silenced. Expression of CC3 also inhibits repair of oxidative DNA damage and leads to a decrease in levels of nucleoredoxin, that could contribute to the reduced viability of CC3 expressing cells after oxidative insult.
Manipulation of the cellular levels of CC3 alters expression levels and/or subcellular localization of proteins that exhibit nucleocytoplasmic shuttling. This results in altered responses to genotoxic stress and adversely affects DNA damage repair by affecting the recruitment of adequate amounts of required proteins to proper cellular compartments. Excess of cellular CC3 has a significant negative effect on DNA repair after UV and oxidant exposure, while silencing of endogenous CC3 slightly delays repair of UV-induced damage.
- U373 Cell
- Nucleotide Excision Repair
- MCF10A Cell
- Cyclobutane Pyrimidine Dimer
- Host Cell Reactivation
The human gene CC3/TIP30 was originally identified as a metastasis-suppressor of variant small cell lung carcinoma (vSCLC) . CC3 is a phylogenetically conserved protein whose expression is absent or much reduced in a variety of aggressive or metastatic tumors such as vSCLC , neuroblastoma and glioblastoma [2, 3], metastatic breast cancer , gastric cancer , hepatocellular carcinoma [6, 7], colorectal carcinomas  and lung cancers with poor prognosis . Forced expression of CC3 in vSCLC , mouse melanoma, breast carcinoma , hepatocellular carcinoma  and gastric carcinoma cell lines  inhibits metastatic behavior in vitro and/or metastasis in vivo. The deletion of CC3 in germline results in spontaneous tumorigenesis in mice , and CC3-null mammary epithelial cells undergo immortalization in vitro  indicating that CC3 could be not only a metastasis suppressor, but also a tumor suppressor . One study on the role of TIP30 in metastasis reported that TIP30 expression actually enhances growth and metastatic behavior of prostate carcinoma cells in vitro , but majority of published results support the hypothesis that CC3/TIP30 suppresses tumor development and metastasis.
High levels of acutely overexpressed exogenous CC3 induce apoptosis [1, 3] while stable expression of exogenous CC3 results in sensitization of cells to apoptosis after treatment with a variety of factors such as serum withdrawal, cytotoxic drugs, γ-irradiation, and microtubule poisons . Expression of CC3 in CC3-negative tumor cells has an inhibitory effect on the ability of these cells to produce angiogenic factors in vitro , consistent with the conclusion that down regulation of CC3 contributes to the development of aggressive metastatic phenotypes.
The precise cellular function of CC3 remains obscure. A significant sequence homology was reported between CC3 and short-chain dehydrogenases-reductases or SDRs [15, 16]. CC3 sequence contains a domain, well conserved between CC3 and SDR enzymes, that was predicted to serve as a NADP(H) binding site [15, 16], and the structural analysis of CC3 protein confirmed this prediction . A clue to the potential cellular function of CC3 came from the findings that CC3 plays an unanticipated inhibitory role in the regulation of nuclear transport . CC3 binds directly to the karyopherins of the importin β family in a RanGTP-insensitive manner and associates with nucleoporins in vivo. CC3 inhibits nuclear import of proteins with either the classic nuclear localization signal (NLS) recognized by importin α:β1, or the M9 signal recognized by transportin (importin β2). Cells modified to express higher levels of CC3 are predisposed to apoptosis and have a slower rate of nuclear import . CC3 protein with mutated NADP(H) binding site lacks pro-apoptotic activity, is displaced from transportin by RanGTP, and fails to inhibit nuclear import in vitro and in vivo. Our results suggest that the ability of CC3 to form a RanGTP resistant complex with importins and the NPC is central to its ability to inhibit nuclear import and induce apoptosis .
An independent confirmation for the function of CC3 as a negative regulator of nuclear transport came from other studies. CC3 was shown to be aberrantly expressed in the oligodendrocyte precursors found in the lesions associated with multiple sclerosis. These high levels of CC3 cause the arrest of the nuclear import of the intracellular domain of Notch (NICD). In these cells NCID, rather that accumulating in the nuclei, is sequestered in cytoplasm in a complex with importin and CC3/TIP30 . The observed lack of the nuclear translocation of NICD leads to the failure of remyelinaiton that could play a causative role in pathogenesis of multiple sclerosis .
The function of CC3 in nuclear transport is likely to be evolutionarily conserved. A large scale two-hybrid analysis of the yeast proteome uncovered that the S. cerevisiae homologue of CC3, YER004w, interacts with exportin CRM1 and with NTF2 , the import factor for RanGDP. Global analysis of yeast transcriptome changes after exposure to DNA damaging treatments strongly indicates that CC3 might be also involved in the DNA damage responses. The yeast homologue of CC3, YER004w belongs to a small group of nine genes that are known as "DNA damage signature set" . Transcription of this group of genes, including YER004w, is increased significantly and specifically after several different types of DNA damage in a MEC1 (ATR homologue)-dependent manner . Additionally, six of the genes in the DNA damage signature set, among them YER004w, are expressed at higher levels in the dna2-1 replication mutant that undergoes premature aging most likely due to the spontaneously accumulating DNA damage . These data, and the possibly conserved role of YER004w in nuclear transport in yeast, indicate that the yeast homologue of CC3 could be involved in control of nuclear transport in response to DNA damage.
We have initiated this work to examine the potential role of human CC3 in regulation of DNA damage responses. We report here that enforced expression of exogenous CC3 significantly impairs the repair of DNA after exposure to UV and oxidative agent as well as negatively influences cell survival, while silencing of endogenous CC3 in human cells has a mild delaying effect on repair of UV induced damage. Our results are consistent with findings that demonstrate a role for CC3 in decreasing cell survival in response to a variety of death signals including DNA damage.
Excess of CC3 impairs the repair of DNA damage
For the initial assessment of the potential effects of CC3 on repair of UV induced DNA damage we have employed the host cell reactivation assay (HCR). HCR is a transfection-based assay in which cells repair transfected UV damaged reporter plasmid. Through measurement of the activity of a reporter enzyme, the relative amount of damaged plasmid that a cell can "reactivate" or repair, and express, can be quantified. We have used a firefly luciferase reporter plasmid damaged by UV and a Renilla luciferase plasmid as an internal control of the transfection efficiency. These luciferase plasmids were co-transfected into recipient HeLa cells along with the effector plasmids (empty vector or CC3-expressing), and dual luciferase activity assays were performed 24 hours after transfection.
To confirm the inhibitory role of CC3 in UV induced DNA damage repair, HCR was conducted in CC3-negative glioblastoma cell line U373 stably transfected with exogenous CC3 ( and Figure 1B). Out of several CC3-negative transformed cell lines that were stably transfected with CC3 , we have chosen the U373 cells because, unlike in other lines, expression of exogenous CC3 had no noticeable effect on the proliferation rate of U373, and did not induce an appreciable increase in their susceptibility to apoptotic stimuli such as UV irradiation or DNA damaging drugs (data not shown; Additional File 1). This allowed monitoring the repair of DNA damage without interference from the different growth rates or from differential induction of cell death by UV. A control clone transfected with empty vector (U373neo) and a clone expressing moderate levels of CC3 (U373cc3) were used in HCR assay with luciferase reporters. Figure 1C shows that in U373neo cells the repair is more efficient that in U373cc3, thus confirming the inhibitory effect of CC3 on DNA damage repair in an additional cellular context.
Stably expressed exogenous CC3 delays repair of both CPDs and 6-4PPs
Repair of CPD was monitored over a period of 24 hours. Figure 2B shows that removal of CPD is also significantly delayed in U373cc3 cells, and after 24 hours 60% of CPDs remain unrepaired in DNA from U373cc3 cells versus less than 40% in control cells.
We have examined if delays in DNA damage repair observed in U373cc3 cells have an effect on cell viability or proliferation. Cell death assays (binding of Annexin V and permeability to propidium iodide) showed no appreciable apoptosis or non-apoptotic cell death in either of U373 clones subjected to UV at 15 J/m2 (not shown). The short term (up to 72 hours) cell proliferation was quantified using CCK-8 assay, and Figure 2C shows that proliferation after UV exposure was somewhat slower in U373cc3 cells, but the decrease was relatively minor. The colony formation after UV exposure was affected by CC3 only slightly, decreasing the number of colonies formed by U373cc3 cells by 5 to 10% compared to U373neo (not shown). Glioblastoma cells are notoriously resistant to death induced by DNA damage, and expression of CC3 apparently does not affect the apoptotic resistance of these cells.
Silencing of CC3 has a modest effect on the repair of CPD lesions
To examine if the results obtained using MCF10A cells with silenced CC3 are unique to this cell line, we have silenced CC3 expression in a breast cancer cell line MCF7. We have again observed a modest delay in the removal of CPD (Figure 3C). To further confirm these results, we performed immunoblot analysis of DNA from UV-irradiated cells with a different anti-CPD antibody. As shown in Figure 3D, the delay in repair in cells with silenced CC3 was also detected by blotting assay in MCF7 cells, as well as in MCF10A cells (not shown). This confirms that the reduction in the levels of endogenous CC3 has a modest delaying effect on repair of UV induced DNA damage. This minor delay in the repair of CPD in absence of CC3 had no effect on the viability of cells after UV exposure (not shown). However, we have observed that silencing of CC3 had a negative effect on cell proliferation after UV exposure (see below).
Changes in gene expression in cells forced to express CC3
To address the possible causes of the impaired repair of UV induced DNA damage we have conducted expression array analysis of U373neo and U373cc3 cells, before and after treatment with UV. The array analysis showed expression changes in a large number of transcripts in untreated U373cc3 cells compared to U373neo (Additional File 2). These transcripts represented genes that could be involved in a wide variety of cellular processes. Examination of genes induced by UV exposure showed that in general transcriptional responses to UV of U373 cells with or without CC3 expression are very similar; i.e. same mRNAs are induced or repressed in both cell lines, with a few exceptions (Additional File 3). This indicates that the transcriptional program induced by UV remains essentially unchanged in presence of exogenous CC3.
Two of the transcriptional changes observed in CC3 expressing cells versus parental U373 cells could be directly related to the differences in the UV induced DNA damage repair between the clones. Array results showed a rather high upregulation of the c-FOS transcript (13.2 fold) in untreated U373cc3 cells versus U373neo, and 2.7 fold downregulation of DDB2 (Additional File 2). c-FOS is an early response gene induced by UV , and was shown to be required for the efficient repair of the UV-induced DNA damage [24–26]. DDB2, also known as Xeroderma pigmentosum group E, is intimately involved in the nucleotide excision repair (NER) of DNA damage by recruiting ubiquitinating protein complex of DDB1-cullin 4A .
We have then examined expression of c-FOS in cells with silenced CC3, expecting that perhaps the latter will have an enhancing effect on c-FOS induction by UV. Indeed, while there was no change in the basal levels of c-FOS in MCF10A cells with silenced CC3, induction of this protein by UV was much higher in MCF10A cells with silenced CC3 (Figure 4B). These observations suggest that both endogenous and exogenous CC3 might restrain induction of c-FOS by UV in different cellular contexts.
CC3 expression increases levels and nuclear localization of p21CIP1
In a recent publication, CC3 was reported to regulate levels of p53 and p21WAF1/CIP1 (CDKN1A) via stabilization of their mRNAs . In addition, p21 protein levels have been shown to be regulated by DDB2 . We have therefore examined if manipulation of CC3 affects the levels of p21CIP1 because p21CIP1 was shown to be involved in the UV induced DNA damage response in numerous publications. Western blot analysis of U373 cells for p21CIP1 showed somewhat lower levels in U373cc3 cells compared to U373neo, and disappearance of detectable p21 after UV exposure. We could not reliably examine the subcellular localization of p21CIP1 by immunofluorescence in U373 cells because these cells have very low levels of p21CIP1 most likely due to the lack of functional p53.
We have therefore examined levels and localization of p21 in CC3 protein null HepG2 cells that express p53. HepG2 cells were transduced with a CC3 expressing lentivirus (HepG2cc3) or a control vector (HepG2con). Expression of exogenous CC3 in HepG2 cells lead to a decrease in the basal levels of p21CIP1, and prevented the increase in its levels and nuclear localization after UV exposure observed in HepG2con cells (Figure 5C and 5D). Changes in levels and localization of p21CIP1 in cells with exogenously expressed CC3 are likely independent of p53-dependent regulation of p21, because the levels of p53 were only marginally affected by CC3 expression (Figure 5C), and the exclusively nuclear localization of p53 in HepG2 cells was not affected by CC3 (not shown).
Examination of MCF10A and MCF7 cells with silenced CC3 showed that in both cell lines abrogation of CC3 protein expression leads to increased basal levels of p21, but no further increase at 2 hours after UV exposure, unlike in control cells (Figure 5B). Silencing of CC3 did not affect the levels of p53 in cells before or 2 hours after UV exposure (Figure 5) (levels of p53 were increased at later times after UV exposure in both control and CC3-silenced cells; not shown). We have examined the subcellular localization of p21CIP1 in cells before and after UV irradiation. In untreated cells, similar percentages of cells had predominantly nuclear p21CIP1 irrespective of their CC3 status, but exposure to UV led to the nuclear accumulation of p21CIP1 in a higher percentage of CC3-silenced cells (Figure 5E). We have not detected changes in localization of p53 protein as a consequence of CC3 silencing (not shown). We conclude that lack of CC3 expression leads to increased nuclear localization of p21 after DNA damage.
Even though p21CIP1 has been implicated in regulation of DNA damage repair itself, some older and recent publications suggest that it is a negative regulator of the translesion (TSL) DNA synthesis after UV exposure. To examine if TSL is affected in MCF10cc3-si cells, we have examined the rate of DNA synthesis after UV exposure. Figure 5F shows that the number of cells in S phase after UV irradiation was significantly reduced in MCF10Acc3-si cells, which have higher levels of p21 that the control cells (Figure 4B). Considering that the effect of CC3 silencing on the efficiency of DNA repair was relatively minor in MCF10A and MCF7 cells (Figure 3), we conclude that the silencing of CC3 has a minor effect on the efficiency of DNA repair but strongly impairs the translesion DNA synthesis probably through increase in levels of nuclear p21.
Exogenous CC3 affects repair of oxidative DNA damage
The array expression analysis of U373 clones (Additional File 2) identified nucleoredoxin , a gene of the peroxiredoxin family, as downregulated 13.7 fold in U373cc3 cells. Nucleoredoxin (NXN) is involved in regulation of Wnt signaling pathway during oxidative stress and , and similar to the other members of the peroxiredoxin family, could be related to the control of the reactive oxygen species after oxidative insult. We examined levels of nucleoredoxin first by quantitative RT-PCR in U373 and N417 cell lines with and without CC3 and confirmed a very significant decrease in the transcript levels in presence of CC3 (Figure 6C).
Next, we have examined the levels of the nucleoredoxin protein by Western blot analysis. Unexpectedly, nucleoredoxin levels were not diminished in U373cc3 cells compared to U373neo cells in spite of the very significant reduction in RNA level (Figure 6D). Therefore, in U373 cells the impairment of the oxidative DNA damage repair is unlikely to be a direct or indirect consequence of the reduced levels of nucleoredoxin. In addition, the levels of both endogenous and peroxide treatment induced reactive oxygen species (ROS) in U373cc3 and U373neo cells were quantitatively similar, as measured by flow cytometric analysis of cells pre-loaded with ROS- sensitive probe CM-H2DCFDA (Molecular Probes; not shown). Analysis of cell survival after treatment with peroxide showed that it is diminished in U373 cells (Figure 6E), indicating that the delayed repair of oxidative damage might impact cell survival.
Because we have observed that in U373cc3 cells transcriptional changes are not necessarily "translated" into corresponding changes in protein levels (as seen with c-FOS, EGR1 and nucleoredoxin), we have examined expression of nucleoredoxin in other cells stably transfected with CC3. In N417cc3 cells nucleoredoxin protein was almost undetectable (Figure 6D). A significant reduction in nucleoredoxin protein levels was seen in two other lines forced to stably express exogenous CC3: CC3-negative neuroblastoma SKNSH and CC3-low breast carcinoma MDA MB 468 (Figure 5D). This suggests that suppression of nucleoredoxin expression by CC3 might be a common consequence of forced CC3 expression.
Our data show that the forced expression of exogenous CC3 and, to a much lesser degree, silencing of endogenous CC3 delay the repair of UV induced DNA damage. These findings are not entirely contradictory considering the role of CC3 in the regulation of nuclear transport. Changes in levels of CC3 could disrupt the existing balance in the nuclear import and export of any number of shuttling proteins, including those involved in DNA damage repair.
We have chosen to examine the possible consequences of forced expression of CC3 on DNA damage repair in a glioblastoma cell line lacking endogenous CC3, because introduction of CC3 did not affect its proliferation rate or sensitivity to death signals, unlike negative effects reported in many other tumor cell lines stably transfected with CC3 (). Therefore, we were able to analyze effects of CC3 on DNA damage repair apart from the described negative effects of CC3 expression on cell survival and growth rate. In retrospect, however, we observed that some transcriptional changes induced by CC3 in U373 cells did not result in corresponding changes in protein levels (increases in c-FOS, EGR-1 and a decrease in nucleoredoxin). The lack of correlation between a change in a certain mRNA level and a corresponding change in level of protein it encodes appears to be limited to U373 cells. In particular, the FOS protein is induced by CC3 in HepG2 but not in U373 (Figure 4B); nucleoredoxin is downregulated by CC3 in three tumor cell lines but not in U373 (Figure 6D); vimentin, whose RNA is upregulated 300 fold in U373cc3 cells (Additional File 2) is practically unchanged at the protein level, but is strongly induced in N417 cells (data not shown). It appears that the U373 cells exercise a strong post-transcriptional control of protein levels in U373 cells, either at the level of translation per se, or by altering protein stability. This could be relevant to the ability of these cells to maintain levels of critical proteins that are compatible with the high proliferation rate and apoptotic resistance characteristic for glioblastoma.
We have attempted to identify some of the proteins relevant to DNA damage responses whose levels/localization are affected by changes in CC3 levels. The RNA expression array analysis was based on a rationale that CC3 might affect nucleocytoplasmic shuttling of certain transcription factors, which could have consequences for the expression levels of a number genes that are co-regulated by these transcription factors. In particular, we were interested to find if the introduction of CC3 into CC3-negative cells might have a generalized effect on transcription changes induced by UV. As seen in the Additional File 3, the sets of genes affected by UV in CC3-negative versus CC3-expressing cells are remarkably similar, excepting a few quantitative changes in the degree of suppression/induction. This indicates that CC3 expression does not induce a major shift in the transcriptional response to UV.
This is, perhaps, not surprising, considering that cells differing in CC3 expression could be expected to have significant changes in subcellular localization of the relevant shuttling proteins rather than changes in their mRNA levels. We have detected changes in the expression levels of two proteins closely related to NER: DDB2 and p21CIP1; in addition, the well-known induction of c-FOS by UV was significantly inhibited in CC3-expressing cells, and increased in CC3-silenced cells (Figure 4). The role of DDB2/XPE in NER has been studied extensively, but remains incompletely understood. Thus, degradation of DDB2 is thought to be essential for the initial stages of NER, but DDB complex activity is dispensable for the NER in vitro ( and references therein). The prevailing notion was that DDB2 is an essential part of the UV-activated DDB1-DDB2-CUL4A ubiquitin ligase, and as such participates in the initiation of global NER. This complex was variously reported to be responsible for degradation of DDB2 itself  or ubiquitination of histones at the sites of damage [36, 37]. However, a very recent report showed that ablation of Cul4A, a ubiquitin ligase in the complex, actually increases the capacity of normal cells to repair UV damaged DNA . DDB2 was shown to act as a haploinsufficient tumor suppressor , but to complicate the issue further, DDB2 is expressed at higher levels in estrogen receptor positive breast cancer cells, and its knockdown negatively impacts the growth rate of these cells . This, however, could be due to the functions that DDB2 likely has in cellular processes other than NER. We show that DDB2 levels are increased in MCF10A and MCF7 cells when CC3 expression is silenced, and DDB2 levels are decreased in U373 cells forced to express CC3. The latter change correlates with a slower kinetics of UV induced DNA damage repair. We conclude that expression of CC3 has an inhibitory effect on expression of DDB2, and that could play a role in the delay of DNA repair.
The role of p21CIP1WAF/CIP1 in NER remains controversial, in spite of hundreds of research papers published on the topic. Earlier reports indicated that higher levels of p21CIP1 are not inhibitory for NER, but can inhibit translesion DNA synthesis (TLS) , while subsequent publications suggested an inhibitory role of p21 in the repair process itself via its interaction with PCNA (reviewed in ). p21 was strongly implicated in the negative regulation of TLS, preventing association of polymerase eta with PCNA [43–45]. Our findings show that increased levels of p21CIP1 in cells where CC3 is silenced correlate with the significant inhibition of TLS, but have a minor effect on UV induced DNA damage repair.
We have also investigated the effect of manipulating levels of CC3 on the DNA damage repair and cell survival after oxidative stress. While we could not detect any effects of CC3 knockdown on the repair of oxidative DNA damage, excess of cellular CC3 significantly delayed repair, and, in addition, had a negative effect on cell proliferation. These findings are in agreement with the published results that overexpression of CC3 leads to increased sensitivity to the apoptotic induction by oxidative stress . An increase in levels of p53 and p21 proteins trough the stabilization of the p53 RNA was suggested to play a role in predisposition to apoptosis induced by CC3 expression.
It is possible that the delays in repair of oxidative DNA damage induced by CC3 might contribute to the lower survival of glioblastoma cells expressing exogenous CC3 (Figure 6E). Other cell lines forced to express CC3 (Figure 6D) also show an impaired survival after treatment with oxidative agents (not shown). In these cell lines, the negative effect on viability could be due not only to impaired DNA repair, but also to a decrease in levels of nucleoredoxin, induced by CC3 (Figure 5). Lower levels of nucleoredoxin in cells forced to express CC3 could result in lowered ability to neutralize ROS, more severe DNA and other types of oxidative damage, and consequently more death. Indeed, N417 cells expressing exogenous CC3 have higher levels of endogenous ROS as measured by conversion of ROS-sensitive probe CM-H2DCFDA to fluorescent form (data not shown). The possible role of nucleoredoxin in this process has not been studied, but peroxiredoxins in general have been implicated in the ability of both Saccharomyces cerevisiae  and mammalian cells  to protect themselves from the deleterious effects of oxidative insults on DNA repair, genomic stability and survival. Nucleoredoxin was shown to act as a negative regulator of the Wnt/β-catenin signaling in peroxide-treated cells . The long-term consequences of this effect on cell survival have not been investigated. However, assuming that nucleoredoxin shares with other peroxiredoxins the ability to control ROS levels, it is reasonable to suggest that lowering levels of cellular nucleoredoxin will have an adverse effect on cell survival after oxidative insult.
Our experiments show that exogenously expressed CC3, by virtue of its effects on levels and subcellular localization of proteins involved in DNA damage responses, negatively affects DNA damage repair after both UV exposure and oxidative stress. We have identified c-FOS, DDB2 and p21CIP as proteins whose levels or localization are affected by CC3, and these changes are potential culprits in the effects of CC3 on cellular responses to UV. Our findings are consistent with the known role of CC3/TIP30 in impairing cell survival after apoptotic treatments and its role as a tumor and metastasis suppressor. Inhibition of nuclear transport by CC3 most likely plays a role in its activity as metastasis suppressor and cell death promoter. Further work will be needed to identify critical proteins whose localization is affected by CC3 and impacts responses to DNA damage.
Cells, transduction and transfection
All cell lines were obtained from the ATCC, and propagated according to the instructions provided. SiRNA constructs in the LKO plasmid vector for the production of lentivirus - mediated siRNA expression were purchased from Open Biosystems/Thermo. Viruses were produced in HEK293 cells according to the manufacturer's instructions and used to transduce cells, followed by selection in pre-determined concentration of puromycin. Stably transfected clonal populations of U373, N417 and SKNSH cells were selected and described earlier [2, 3].
The HCR assay was conducted as described previously . The firefly luciferase reporter plasmid (pFLuc) either damaged with 1000 J/m2 or undamaged was contransfected with undamaged Renilla luciferase pRLuc as an internal transfection control and with effector plasmids: pCMVneo3, pCMV-CC3 and pCMV-CC3 mut with Fugene (Roche) on 24 well plates. At 24 hours after transfection, cells were lyzed and assayed for Renilla and Firefly luciferase activity using the Dual Luciferase Activity assay (Promega). The firefly luciferase activity of each sample was normalized to the Renilla activity. To determine the repair capacity of cells transfected with different reporters, repair conversion was calculated first by dividing the normalized firefly luciferase activity from cells transfected with the UV-damaged pFLuc by that of undamaged pFLuc transfected cultures. The fold HCR was calculated by dividing the repair conversion of effector transfectants by that of vector transfectants.
Comet assays were conducted using Trevigen comet assay kits according to manufacturer's instructions. Briefly, cells were harvested by trypsinization at different times after treatment with UV or hydrogen peroxide, and embedded into low-melting agarose. Embedded cells were gently lyzed, and the nuclear DNA was denatured with alkali. Cells in agarose were subjected to electrophoresis in the alkaline buffer, and after drying were stained with SYBRgreen. Comets were counted under fluorescent microscope. At least 300 nuclei were counted for each sample.
Detection of CPDs by ELISA
Cells were seeded on 6-cm culture dishes at 5 × 105 per well and irradiated next day with 15 J/m2
UVC. Cells were harvested immediately or at different times after irradiation, and genomic DNA was isolated (DNeasy cell and tissue kit; Qiagen). ELISA (in triplicate) was performed in 96-well plates precoated with 0.06% protamine sulfate (Sigma). For CPD detection with TDM-2 antibody (Cosmo Bio), 30 ng of heat-denatured DNA in PBS was added to the wells and dried at 37°C for 16-20 h. The monoclonal antibody TDM-2 was added to the wells at 0.05 μg/ml and incubated at 37°C for 30 min. The plates then were incubated with affinity-purified goat anti-mouse immunogloblin G conjugated with peroxidase (Zymed) at 37°C for 90 min. Finally, the substrate solution, consisting of 0.04% o-phenylene diamine and 0.007% H2O2 in citrate-phosphate buffer, was added to each well for 30 minutes. Sulfuric acid was added to stop the reaction and the absorbance at 490 nm was measured using a Microplate Reader Spectra MAX.
Detection of CPDs by Immuno-slot blot
100 ng of DNA was diluted into DNA denaturation solution (1.5 M NaCl: 0.5 M NaOH) and applied to a positively charged nylon membrane by vacuum blotting. The DNA on membrane was washed with a neutralizing buffer (0.5 M Tris; 1.0 M NaCl, pH 7.5). The membrane was baked at 80°C for 20 minutes and blocked by incubating in PBS plus 0.1% Tween 20 (PBS-T) containing 5% nonfat milk (blocking buffer) overnight at 4°C. After multiple washes with PBS-T, the membrane was incubated with anti-CPD antibody (Kamiya) in blocking buffer for 2 h at room temperature. The membrane was washed thoroughly with PBS-T and further incubated with an anti-mouse horseradish peroxidase-conjugated antibody (Pierce) for 1 h at room temperature (1:5,000 dilution in PBS-T). The membrane was developed with the chemiluminescence detection kit (Pierce) and detected on Kodak Imager 2000R using Kodak Molecular Imaging software.
Cell viability tests
Short term effects of various treatments were analyzed using the WST-8 cell proliferation assay with the Cell counting kit CCK-8 from Dojindo. Briefly, cells were plated on 96 well palates, subjected to treatments in triplicates or quadruplicates, and the number of live cells was evaluated one, two and three days later. For colony-forming assay, cells were plated at 1000 on 6 cm plates overnight, and subjected to UV exposure. Fifteen days later the colonies were stained with Crystal Violet and counted.
Whole cell lysates were prepared in RIPA buffer (140 mM NaCl, 50 mM Tris pH 8.0, 1 mM EDTA. 1 mM DTT, 0,5% deoxycholate, 0.1% SDS, 1% Triton X100 and protease inhibitors). For analysis of DDB2, RIPA buffer contained 420 mM NaCl. Cell lysates were electrophoresed on SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blotted with antibodies at recommended concentrations overnight at 4°C and the bound primary antibodies were detected using peroxidase-conjugated secondary antibodies. Blots were developed using SuperSignal enhanced chemiluminescence kit (Pierce) and imaged on Kodak Imager ISR2000.
RNA isolation and microarray analysis
U373neo and U373cc3 were exposed to UV at 15 J/m2 and left to recover for 2 hours. These cells, along with untreated cells, were each harvested in triplicates for microarray experiment. Total RNA was isolated using RNeasy Mini Kit (Qiagen). RNA was used for Cy5-labeled aRNA preparation per manufacturer instruction (Ambion MessageAmp™ aRNA Amplification Kit, Ambion Inc., Austin, TX, USA).
The microarray experiments were performed using Phalanx Human OneArray™ Version 4.1 (HOA 4.1; Phalanx Biotech Group, Inc., Hsinchu, Taiwan). Each microarray contains 32,050 oligonucleotide probes that include 30,968 human gene probes for transcription expression profiling and 1082 experimental control probes. Detailed descriptions of the gene array list, hybridization and processing procedures are available from http://www.phalanxbiotech.com/.
In brief, each Cy5 labeled aRNA was hybridized to HOA 4.1 microarrays in triplicate. Prior to the microarray hybridization, the Cy5 labeled aRNAs were fragmented using the reagents and protocol provided in Ambion RNA Fragmentation Reagents kit (Ambion Inc., Austin, TX). Fragmented Cy5-labeled aRNA were suspended in OneArray™ hybridization buffer (provided in HOA product package) at a final volume of 180 μl per hybridization. The pre-hybridization blocking, array hybridization, and post-hybridization washes were performed according to the instruction provided in the HOA User Guide. The arrays were then scanned using GenePix 4000B (Molecular Devices, Sunnyvale, CA, USA) and the fluorescent intensities were extracted from the generated images by following the instructions and the conditions described in HOA User Guide. The raw intensity data were input to GeneSpring GX Version 7.3.1 (Agilent, Foster City, CA, USA). The averaged intensities for each probe then were normalized by quantile normalization. Differentially expressed genes were identified, and filtered based on t-tests (p < 0.05). The results of microarray analysis are available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20633
Real-Time Quantitative PCR
Total RNA was isolated as described above. Five μg of total RNA was treated with 20 units of DNase and reverse transcribed with oligo dT:random primer (1:1 at 1.5 μg each) by using Superscript II (Invitrogen). Fifty nanograms of first-strand cDNA were used in subsequent real-time PCR carried out with iQ5 (Bio-Rad) by using SyBr green dye (Applied Biosystems) as the fluorescent probe with gene-specific primer sets. The following parameters were used in the PCR: 10 min denaturation at 95°C, 35 cycles of 15 sec at 95°C, and 1 min at 55°C. To quantify fold expression changes compared to control, the ΔΔCT methods were used . CT is the point at which the fluorescence signal rises above the baseline fluorescence and begins to increase exponentially. The CT value is in logarithmic inverse relationship with the abundance of the transcripts, based on the assumption that CT values increase by 1 for each twofold dilution.
Cells were plated on 8-well chamber slides, treated as intended next day and fixed in 4% paraformaldehyde. After permeabilization with 0.1% Triton X-100 and blocking in 3% BSA in PBS, cells were incubated with anti-p21CIP1 antibodies (Cell Signaling) and anti-CC3 antibodies  in 1% BSA, and bound antibodies detected with the appropriate secondary antibodies conjugated to Alexa 488 or 568 (Invitrogen).
Cells in culture were incubated with 30 μM of BrdU for 30 minutes, after which BrdU containing media were removed, cells washed with PBS and incubated for additional 1.5 hours in fresh media. Cells were harvested, fixed in 70% ethanol and processed for staining with anti-BrdU, FITC-conjugated antibody (Becton Dickinson) according to supplier's protocol. Cells were counterstained with propidium iodide and analyzed on FACScan.
We are grateful to Dr. H. Miki (University of Tokyo) for the gift of the anti-nucleoredoxin antibody. This work was supported by the grant to ES (R01CA114430) from the National Cancer Institute.
- Shtivelman E: A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene. 1997, 14: 2167-2173. 10.1038/sj.onc.1201059.View ArticlePubMedGoogle Scholar
- NicAmhlaoibh R, Shtivelman E: Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene. 2001, 20: 270-275. 10.1038/sj.onc.1204075.View ArticlePubMedGoogle Scholar
- Whitman S, Wang X, Shalaby R, Shtivelman E: Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol Cell Biol. 2000, 20: 583-593. 10.1128/MCB.20.2.583-593.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F, Yan X, Lu B, Xu H, Guo Y: TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol. 2007, 38: 293-298. 10.1016/j.humpath.2006.08.005.View ArticlePubMedGoogle Scholar
- Li X, Zhang Y, Cao S, Chen X, Lu Y, Jin H, Sun S, Chen B, Liu J, Ding J: Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis. Int J Cancer. 2009, 124: 713-721. 10.1002/ijc.23967.View ArticlePubMedGoogle Scholar
- Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M: Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clin Cancer Res. 2008, 14: 7405-7412. 10.1158/1078-0432.CCR-08-0409.View ArticlePubMedGoogle Scholar
- Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y: TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology. 2006, 44: 205-215. 10.1002/hep.21213.View ArticlePubMedGoogle Scholar
- Chen X, Cao X, Dong W, Luo S, Suo Z, Jin Y: Expression of TIP30 Tumor Suppressor Gene Is Down-Regulated in Human Colorectal Carcinoma. Dig Dis Sci. 2009Google Scholar
- Tong X, Li K, Luo Z, Lu B, Liu X, Wang T, Pang M, Liang B, Tan M, Wu M: Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol. 2009, 174: 1931-1939. 10.2353/ajpath.2009.080846.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu Y, Thor A, Shtivelman E, Cao Y, Tu G, Heath TD, Debs RJ: Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J Biol Chem. 1999, 274: 13338-13344. 10.1074/jbc.274.19.13338.View ArticlePubMedGoogle Scholar
- Xiao H, Palhan V, Yang Y, Roeder RG: TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. Embo J. 2000, 19: 956-963. 10.1093/emboj/19.5.956.PubMed CentralView ArticlePubMedGoogle Scholar
- Pecha J, Ankrapp D, Jiang C, Tang W, Hoshino I, Bruck K, Wagner KU, Xiao H: Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland. Oncogene. 2007, 26: 7423-7431. 10.1038/sj.onc.1210548.View ArticlePubMedGoogle Scholar
- Ito M, Jiang C, Krumm K, Zhang X, Pecha J, Zhao J, Guo Y, Roeder RG, Xiao H: TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res. 2003, 63: 8763-8767.PubMedGoogle Scholar
- Zhang H, Zhang Y, Duan HO, Kirley SD, Lin SX, McDougal WS, Xiao H, Wu CL: TIP30 is associated with progression and metastasis of prostate cancer. Int J Cancer. 2008, 123: 810-816. 10.1002/ijc.23638.View ArticlePubMedGoogle Scholar
- Baker ME: TIP30, a cofactor for HIV-1 Tat-activated transcription, is homologous to short-chain dehydrogenases/reductases. Curr Biol. 1999, 9: R471-10.1016/S0960-9822(99)80297-8.View ArticlePubMedGoogle Scholar
- Baker ME, Yan L, Pear MR: Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci. 2000, 57: 851-858. 10.1007/s000180050047.View ArticlePubMedGoogle Scholar
- El Omari K, Bird LE, Nichols CE, Ren J, Stammers DK: Crystal structure of CC3 (TIP30): implications for its role as a tumor suppressor. J Biol Chem. 2005, 280: 18229-18236. 10.1074/jbc.M501113200.View ArticlePubMedGoogle Scholar
- King FW, Shtivelman E: Inhibition of nuclear import by the proapoptotic protein CC3. Mol Cell Biol. 2004, 24: 7091-7101. 10.1128/MCB.24.16.7091-7101.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Nakahara J, Kanekura K, Nawa M, Aiso S, Suzuki N: Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest. 2009, 119: 169-181.PubMed CentralPubMedGoogle Scholar
- Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA. 2001, 98: 4569-4574. 10.1073/pnas.061034498.PubMed CentralView ArticlePubMedGoogle Scholar
- Gasch AP, Huang M, Metzner S, Botstein D, Elledge SJ, Brown PO: Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol Biol Cell. 2001, 12: 2987-3003.PubMed CentralView ArticlePubMedGoogle Scholar
- Lesur I, Campbell JL: The transcriptome of prematurely aging yeast cells is similar to that of telomerase-deficient cells. Mol Biol Cell. 2004, 15: 1297-1312. 10.1091/mbc.E03-10-0742.PubMed CentralView ArticlePubMedGoogle Scholar
- Buscher M, Rahmsdorf HJ, Litfin M, Karin M, Herrlich P: Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene. 1988, 3: 301-311.PubMedGoogle Scholar
- Christmann M, Tomicic MT, Aasland D, Kaina B: A role for UV-light-induced c-Fos: Stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis. Carcinogenesis. 2007, 28: 183-190. 10.1093/carcin/bgl119.View ArticlePubMedGoogle Scholar
- Christmann M, Tomicic MT, Origer J, Aasland D, Kaina B: c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF. Nucleic Acids Res. 2006, 34: 6530-6539. 10.1093/nar/gkl895.PubMed CentralView ArticlePubMedGoogle Scholar
- Haas S, Kaina B: c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis. 1995, 16: 985-991. 10.1093/carcin/16.5.985.View ArticlePubMedGoogle Scholar
- Shiyanov P, Nag A, Raychaudhuri P: Cullin 4A associates with the UV-damaged DNA-binding protein DDB. J Biol Chem. 1999, 274: 35309-35312. 10.1074/jbc.274.50.35309.View ArticlePubMedGoogle Scholar
- Huang RP, Wu JX, Fan Y, Adamson ED: UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol. 1996, 133: 211-220. 10.1083/jcb.133.1.211.View ArticlePubMedGoogle Scholar
- Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 1988, 53: 37-43. 10.1016/0092-8674(88)90485-0.View ArticlePubMedGoogle Scholar
- Zhao J, Chen J, Lu B, Dong L, Wang H, Bi C, Wu G, Guo H, Wu M, Guo Y: TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res. 2008, 68: 4133-4141. 10.1158/0008-5472.CAN-08-0432.View ArticlePubMedGoogle Scholar
- Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P: The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol. 2008, 28: 177-187. 10.1128/MCB.00880-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Kurooka H, Kato K, Minoguchi S, Takahashi Y, Ikeda J, Habu S, Osawa N, Buchberg AM, Moriwaki K, Shisa H, Honjo T: Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics. 1997, 39: 331-339. 10.1006/geno.1996.4493.View ArticlePubMedGoogle Scholar
- Funato Y, Michiue T, Asashima M, Miki H: The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol. 2006, 8: 501-508. 10.1038/ncb1405.View ArticlePubMedGoogle Scholar
- Wakasugi M, Kasashima H, Fukase Y, Imura M, Imai R, Yamada S, Cleaver JE, Matsunaga T: Physical and functional interaction between DDB and XPA in nucleotide excision repair. Nucleic Acids Res. 2009, 37: 516-525. 10.1093/nar/gkn964.PubMed CentralView ArticlePubMedGoogle Scholar
- El-Mahdy MA, Zhu Q, Wang QE, Wani G, Praetorius-Ibba M, Wani AA: Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J Biol Chem. 2006, 281: 13404-13411. 10.1074/jbc.M511834200.View ArticlePubMedGoogle Scholar
- Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapic-Otrin V, Levine AS: The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci USA. 2006, 103: 2588-2593. 10.1073/pnas.0511160103.View ArticlePubMedGoogle Scholar
- Wang H, Zhai L, Xu J, Joo HY, Jackson S, Erdjument-Bromage H, Tempst P, Xiong Y, Zhang Y: Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell. 2006, 22: 383-394. 10.1016/j.molcel.2006.03.035.View ArticlePubMedGoogle Scholar
- Liu L, Lee S, Zhang J, Peters SB, Hannah J, Zhang Y, Yin Y, Koff A, Ma L, Zhou P: CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol Cell. 2009, 34: 451-460. 10.1016/j.molcel.2009.04.020.PubMed CentralView ArticlePubMedGoogle Scholar
- Itoh T, Iwashita S, Cohen MB, Meyerholz DK, Linn S: Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis. Hum Mol Genet. 2007, 16: 1578-1586. 10.1093/hmg/ddm107.View ArticlePubMedGoogle Scholar
- Kattan Z, Marchal S, Brunner E, Ramacci C, Leroux A, Merlin JL, Domenjoud L, Dauca M, Becuwe P: Damaged DNA binding protein 2 plays a role in breast cancer cell growth. PLoS One. 2008, 3: e2002-10.1371/journal.pone.0002002.PubMed CentralView ArticlePubMedGoogle Scholar
- Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ: Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr Biol. 1994, 4: 1062-1068. 10.1016/S0960-9822(00)00244-X.View ArticlePubMedGoogle Scholar
- Fotedar R, Bendjennat M, Fotedar A: Role of p21WAF1 in the cellular response to UV. Cell Cycle. 2004, 3: 134-137.View ArticlePubMedGoogle Scholar
- Avkin S, Sevilya Z, Toube L, Geacintov N, Chaney SG, Oren M, Livneh Z: p53 and p21 regulate error-prone DNA repair to yield a lower mutation load. Mol Cell. 2006, 22: 407-413. 10.1016/j.molcel.2006.03.022.View ArticlePubMedGoogle Scholar
- Savio M, Coppa T, Cazzalini O, Perucca P, Necchi D, Nardo T, Stivala LA, Prosperi E: Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair. DNA Repair (Amst). 2009, 8: 778-785. 10.1016/j.dnarep.2009.02.005.View ArticleGoogle Scholar
- Soria G, Speroni J, Podhajcer OL, Prives C, Gottifredi V: p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J Cell Sci. 2008, 121: 3271-3282. 10.1242/jcs.027730.View ArticlePubMedGoogle Scholar
- Huang ME, Kolodner RD: A biological network in Saccharomyces cerevisiae prevents the deleterious effects of endogenous oxidative DNA damage. Mol Cell. 2005, 17: 709-720. 10.1016/j.molcel.2005.02.008.View ArticlePubMedGoogle Scholar
- Arner ES, Holmgren A: The thioredoxin system in cancer. Semin Cancer Biol. 2006, 16: 420-426. 10.1016/j.semcancer.2006.10.009.View ArticlePubMedGoogle Scholar
- Liu MT, Chen YR, Chen SC, Hu CY, Lin CS, Chang YT, Wang WB, Chen JY: Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene. 2004, 23: 2531-2539. 10.1038/sj.onc.1207375.View ArticlePubMedGoogle Scholar
- Shichiri M, Kato H, Doi M, Marumo F, Hirata Y: Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol. 1999, 13: 1353-1363. 10.1210/me.13.8.1353.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.